FindTrial
Sign In

The efficacy and safety of glaucoma micro-tube in treating neovascular glaucoma

The efficacy and safety of glaucoma micro-tube in treating neovascular glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112166
Enrollment
Unknown
Registered
2025-11-11
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neovascular glaucoma

Interventions

Observation group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-80 with neovascular glaucoma receiving microinvasive glaucoma drainage implant

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria, or the patient refuses to participate in this observational study

Design outcomes

Primary

MeasureTime frame
intraocular pressure;—

Secondary

MeasureTime frame
Vision;Corneal endothelial cell count;—

Countries

China

Contacts

Public ContactWei Liu

Tianjin Medical University Eye Hospital

weiliu05@tmu.edu.cn+86 22 86428705

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026